Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bang

Showing results (271-280 of 308) with videos related to

Pageof 31
Sort By:
Respiratory Medicine and Research|November 24, 2025
Peridiaphragmatic inflammation and fibrosis in myositis associated interstitial lung disease; a case seriesJoseph B Pryor, Joshua J Solomon, Jeffrey J Swigris, et al.
European Journal of Physical and Rehabilitation Medicine|May 9, 2020
Cardiac rehabilitation and 5-year mortality after acute myocardial infarction. Report from 11 tertiary hospitals in Korea (ETHIK Study)Chul Kim, Insun Choi, Songhee Cho, et al.
Human Gene Therapy|October 6, 1998
Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancerD S Heo, S J Yoon, W S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001A T Shaw, G J Riely, Y-J Bang, et al.
British Journal of Cancer|January 8, 2009
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancerS-W Han, D-Y Oh, S-A Im, et al.
British Journal of Cancer|November 13, 2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectivesJ W Kim, S-J Kim, Y-H Chung, et al.
British Journal of Cancer|March 5, 2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survivalJ-S Kim, M-A Kim, T M Kim, et al.
International Journal of Cancer|February 7, 1997
Establishment and characterization of human gastric carcinoma cell linesJ G Park, H K Yang, W H Kim, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2020
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular SignaturesHaruhiko Furusawa, Jonathan H Cardwell, Tsukasa Okamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinomaK Shitara, M Özgüroğlu, Y-J Bang, et al.
Pageof 31

Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Respiratory Medicine and Research|November 24, 2025
Peridiaphragmatic inflammation and fibrosis in myositis associated interstitial lung disease; a case seriesJoseph B Pryor, Joshua J Solomon, Jeffrey J Swigris, et al.
European Journal of Physical and Rehabilitation Medicine|May 9, 2020
Cardiac rehabilitation and 5-year mortality after acute myocardial infarction. Report from 11 tertiary hospitals in Korea (ETHIK Study)Chul Kim, Insun Choi, Songhee Cho, et al.
Human Gene Therapy|October 6, 1998
Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancerD S Heo, S J Yoon, W S Kim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 14, 2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001A T Shaw, G J Riely, Y-J Bang, et al.
British Journal of Cancer|January 8, 2009
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancerS-W Han, D-Y Oh, S-A Im, et al.
British Journal of Cancer|November 13, 2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectivesJ W Kim, S-J Kim, Y-H Chung, et al.
British Journal of Cancer|March 5, 2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survivalJ-S Kim, M-A Kim, T M Kim, et al.
International Journal of Cancer|February 7, 1997
Establishment and characterization of human gastric carcinoma cell linesJ G Park, H K Yang, W H Kim, et al.
American Journal of Respiratory and Critical Care Medicine|July 1, 2020
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular SignaturesHaruhiko Furusawa, Jonathan H Cardwell, Tsukasa Okamoto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2021
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinomaK Shitara, M Özgüroğlu, Y-J Bang, et al.
Pageof 31